Between November 1988 and January 1992, 19,962 renal and ureteral calculi were treated in the United States using 18 different mobile and 2 fixed base Lithostar lithotriptors. Lithotripsy was performed on 11,516 renal and 8,446 ureteral calculi by 750 urologists using the same technique. The success rate (asymptomatic with stone fragments of 4 mm. or less) for renal stones was 87.9%, the stone-free rate was 68.9% and the retreatment rate was 16.5%. Auxiliary procedures were performed in 32.2% of the renal calculi. The success rate for ureteral calculi was 89.5%, the stone-free rate was 83.5% and the retreatment rate was 10.7%. Auxiliary procedures were performed in 25.5% of the ureteral calculi. The overall success rate was 88.4% stone-free rate 75.5%, retreatment rate 14.0% and auxiliary procedure rate 29.4%. Anesthesia personnel were used in 1.9% of the cases. Low energy extracorporeal shock wave lithotripsy was found to be safe and effective.

Between November 1988 and July 1993, 238 renal stones and 208 ureteral stones were treated in 446 pediatric patients using 26 mobile and 2 fixed base Siemens Lithostar lithotriptors. The stones were treated by a group of 245 urologists using the modified Puigvert technique and the standard shock tube. The success rate for renal stones (asymptomatic fragments less than 4 mm.) was 76.6%, stone-free rate was 67.9%, retreatment rate was 14.1% and ancillary procedures were performed in 36.3%. The stone-free rate for ureteral stones was 91.1%, retreatment rate was 3.5% and ancillary procedures were performed in 17.7%. Anesthesia was required in 31% of the renal and 21% of the ureteral procedures. Sepsis in a 6-year-old child after treatment of a ureteral stone was the only major complication. Low energy lithotripsy with the Lithostar in our series of pediatric patients was safe and effective.

Between November 14, 1988 and August 1, 1993, 18,825 ureteral calculi were treated in the United States using 25 different mobile and 2 fixed base Siemens Lithostar lithotriptors. Lithotripsy was performed by 1,012 urologists using the modified Puigvert technique. The overall stone-free rate was 83.8% with a retreatment rate of 10.8%. The stone-free rate varied from 85.8% with stones of 10 mm. or smaller to 67.9% for stones larger than 20 mm. A ureteral stent or catheter was placed before lithotripsy in 19.3% of all treatments and 80.7% had in situ treatment without instrumentation. For calculi of any size, the use of ureteral stents or catheters had no effect on treatment outcome at any ureteral location.

Anti-factor VIII antibodies, inherited or acquired inhibitors of the factor VIII molecule, have not been reported previously in the urological literature. Although more common in hemophiliac patients who have received multiple transfusions, this anticoagulant may be the cause of severe hemorrhage in nonhemophiliac patients. We describe a patient with carcinoma of the prostate and an unsuspected anti-factor VIII antibody, who experienced excessive postoperative bleeding and prolonged hospitalization following a vesicolithotomy and bilateral orchiectomy. A prolonged partial thromboplastin time and a significant decrease in measurable factor VIII clotting activity in a patient with no history of bleeding problems are essential clues in making the diagnosis of a factor VIII inhibitor. This coagulation defect is treated best with prothrombin complex concentrates, which contain vitamin K dependent clotting factors.

Porcine kidneys containing human calculi of known size and composition were used to study the ability of ultrasound to localize intrarenal calculi. The study conducted in a blind fashion demonstrated that stones as small as 2 mm could be detected. The chemical composition was not related to the ability to detect the stone. Early trials in the operating room have been encouraging. The porcine kidney model is useful for training purposes.